What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?
Rebecca Mercieca-BebberMadeleine T KingMiriam M BoxerAndrew SpillaneZoë E WintersPhyllis N ButowJoan McPhersonClaudia RutherfordPublished in: Breast cancer (Tokyo, Japan) (2017)
Fear of progression is a key consideration in DCIS treatment decision making for women with high health literacy. QOL treatment considerations differed by treatments received. Women diagnosed with DCIS may benefit from evidence about QOL to inform treatment decision making.